Clinical Trial Update: The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

This clinical trial update reports a completed Phase 2 study evaluating nebivolol's effects on the NO-system in patients with essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• BYSTOLIC (nebivolol hydrochloride)

Snippet

Sponsor: Erling Bjerregaard Pedersen | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED